XML 32 R74.htm IDEA: XBRL DOCUMENT v3.20.1
Error Correction (Restated Consolidated Statements) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Dec. 31, 2019
Dec. 31, 2018
Consolidated Statements of Income        
Net Sales $ 137,483 $ 113,822    
Cost of sales 94,536 88,392    
Gross profit 42,947 25,430    
Selling, general and administrative expenses 15,214 13,677    
(Gain) loss on disposition of assets (62) 284    
Income from operations 27,795 11,469    
Interest income, net   9    
Other (expense) income, net (27) (26)    
Income before taxes 27,829 11,452    
Income tax provision 5,976 2,695    
Net income $ 21,853 $ 8,757    
Earnings per share:        
Basic (usd per share) $ 0.42 $ 0.17    
Diluted (usd per share) $ 0.41 $ 0.17    
Weighted average shares outstanding:        
Basic (in shares) 52,071,839 51,992,150    
Diluted (in shares) 52,871,419 52,369,660    
Balance Sheet Data (at end of period):        
Current assets $ 196,966 $ 146,511 $ 187,549  
Total assets 395,620 319,238 371,424  
Current liabilities 64,185 43,082 56,028  
Deferred income taxes 15,130 10,168 15,297  
Other long-term liabilities 3,652 3,442 3,639  
Total stockholders' equity 306,323 262,546 290,140 $ 249,443
Share-based compensation 2,351 5,407    
Profit sharing bonus plan expense 3,167 1,306    
Consolidated Statements of Stockholders’ Equity        
Total stockholders' equity 306,323 262,546 290,140 249,443
Net income 21,853 8,757    
Stock options exercised and restricted stock awards granted 4,497 4,010    
Share-based compensation 2,351 5,407    
Stock repurchased and retired (12,518) (5,071)    
Operating Activities        
Net income 21,853 8,757    
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization 6,002 5,914    
Provision for losses on accounts receivable, net of adjustments 294 115    
Provision for excess and obsolete inventories (274) 357    
Share-based compensation 2,351 5,407    
Loss (gain) on disposition of assets (62) 284    
Foreign currency transaction (gain) loss 51 (16)    
Interest income on note receivable (6) (6)    
Deferred income taxes (167) 909    
Changes in assets and liabilities:        
Accounts receivable (2,789) (4,725)    
Income taxes 772 1,432    
Inventories 1,020 2,678    
Prepaid expenses and other (670) (561)    
Accounts payable 2,742 (5,730)    
Deferred revenue 229 25    
Accrued liabilities and donations 6,241 73    
Net cash provided by operating activities 37,597 14,913    
Investing Activities        
Capital expenditures (21,877) (8,772)    
Proceeds from sale of property, plant and equipment 61 52    
Principal payments from note receivable 12 17    
Net cash used in investing activities (21,804) (8,703)    
Financing Activities        
Stock options exercised 4,497 4,010    
Repurchase of stock (11,565) (4,483)    
Employee taxes paid by withholding shares (953) (588)    
Net cash used in financing activities (8,021) (1,061)    
Net increase in cash, cash equivalents and restricted cash 7,772 5,149    
Cash, cash equivalents and restricted cash, beginning of period 44,373 1,994    
Cash, cash equivalents and restricted cash, end of period 52,145 7,143    
Common Stock        
Balance Sheet Data (at end of period):        
Total stockholders' equity $ 208 $ 208 $ 208 $ 208
Consolidated Statements of Stockholders’ Equity        
Shares, Outstanding 52,044,000 52,099,000 52,079,000 51,991,000
Total stockholders' equity $ 208 $ 208 $ 208 $ 208
Stock options exercised and restricted stock awards granted (in shares) 212,000 237,000    
Stock options exercised and restricted stock awards granted $ 1 $ 1    
Stock repurchased and retired (in shares) (247,000) (129,000)    
Stock repurchased and retired $ (1) $ (1)    
Paid-in Capital        
Balance Sheet Data (at end of period):        
Total stockholders' equity 0 4,346 3,631 0
Consolidated Statements of Stockholders’ Equity        
Total stockholders' equity 0 4,346 3,631 0
Stock options exercised and restricted stock awards granted 4,496 4,009    
Share-based compensation 2,351 5,407    
Stock repurchased and retired (10,478) (5,070)    
Retained Earnings        
Consolidated Statements of Income        
Net income 21,853 8,757    
Balance Sheet Data (at end of period):        
Total stockholders' equity 306,115 257,992 286,301 249,235
Consolidated Statements of Stockholders’ Equity        
Total stockholders' equity 306,115 257,992 $ 286,301 249,235
Net income 21,853 8,757    
Stock repurchased and retired (2,039)      
Operating Activities        
Net income $ 21,853 8,757    
Previously Reported        
Consolidated Statements of Income        
Net Sales   113,822    
Cost of sales   88,029    
Gross profit   25,793    
Selling, general and administrative expenses   11,001    
(Gain) loss on disposition of assets   284    
Income from operations   14,508    
Interest income, net   9    
Other (expense) income, net   (26)    
Income before taxes   14,491    
Income tax provision   3,589    
Net income   $ 10,902    
Earnings per share:        
Basic (usd per share)   $ 0.21    
Diluted (usd per share)   $ 0.21    
Weighted average shares outstanding:        
Basic (in shares)   51,992,150    
Diluted (in shares)   52,369,660    
Balance Sheet Data (at end of period):        
Current assets   $ 146,798    
Total assets   319,525    
Current liabilities   44,000    
Deferred income taxes   12,713    
Other long-term liabilities   3,442    
Total stockholders' equity   259,370   247,499
Consolidated Statements of Stockholders’ Equity        
Total stockholders' equity   259,370   247,499
Net income   10,902    
Stock options exercised and restricted stock awards granted   4,010    
Share-based compensation   2,030    
Stock repurchased and retired   (5,071)    
Operating Activities        
Net income   10,902    
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization   5,914    
Provision for losses on accounts receivable, net of adjustments   115    
Provision for excess and obsolete inventories   357    
Share-based compensation   2,030    
Loss (gain) on disposition of assets   284    
Foreign currency transaction (gain) loss   (16)    
Interest income on note receivable   (6)    
Deferred income taxes   1,887    
Changes in assets and liabilities:        
Accounts receivable   (4,725)    
Income taxes   (1,348)    
Inventories   2,678    
Prepaid expenses and other   (561)    
Accounts payable   (5,730)    
Deferred revenue   25    
Accrued liabilities and donations   411    
Net cash provided by operating activities   14,913    
Investing Activities        
Capital expenditures   (8,772)    
Proceeds from sale of property, plant and equipment   52    
Principal payments from note receivable   17    
Net cash used in investing activities   (8,703)    
Financing Activities        
Stock options exercised   4,010    
Repurchase of stock   (4,483)    
Employee taxes paid by withholding shares   (588)    
Net cash used in financing activities   (1,061)    
Net increase in cash, cash equivalents and restricted cash   5,149    
Cash, cash equivalents and restricted cash, beginning of period   1,994    
Cash, cash equivalents and restricted cash, end of period   7,143    
Previously Reported | Common Stock        
Balance Sheet Data (at end of period):        
Total stockholders' equity   $ 208   $ 208
Consolidated Statements of Stockholders’ Equity        
Shares, Outstanding   52,099,000   51,991,000
Total stockholders' equity   $ 208   $ 208
Stock options exercised and restricted stock awards granted (in shares)   237,000    
Stock options exercised and restricted stock awards granted   $ 1    
Stock repurchased and retired (in shares)   (129,000)    
Stock repurchased and retired   $ (1)    
Previously Reported | Paid-in Capital        
Balance Sheet Data (at end of period):        
Total stockholders' equity   969   0
Consolidated Statements of Stockholders’ Equity        
Total stockholders' equity   969   0
Stock options exercised and restricted stock awards granted   4,009    
Share-based compensation   2,030    
Stock repurchased and retired   (5,070)    
Previously Reported | Retained Earnings        
Consolidated Statements of Income        
Net income   10,902    
Balance Sheet Data (at end of period):        
Total stockholders' equity   258,193   247,291
Consolidated Statements of Stockholders’ Equity        
Total stockholders' equity   258,193   247,291
Net income   10,902    
Stock repurchased and retired   0    
Operating Activities        
Net income   10,902    
Corrections        
Consolidated Statements of Income        
Net Sales   0    
Cost of sales   363    
Gross profit   (363)    
Selling, general and administrative expenses   2,676    
(Gain) loss on disposition of assets   0    
Income from operations   (3,039)    
Interest income, net   0    
Other (expense) income, net   0    
Income before taxes   (3,039)    
Income tax provision   (894)    
Net income   $ (2,145)    
Earnings per share:        
Basic (usd per share)   $ (0.04)    
Diluted (usd per share)   $ (0.04)    
Weighted average shares outstanding:        
Basic (in shares)   0    
Diluted (in shares)   0    
Balance Sheet Data (at end of period):        
Current assets   $ (287)    
Total assets   (287)    
Current liabilities   (918)    
Deferred income taxes   (2,545)    
Other long-term liabilities   0    
Total stockholders' equity   3,176   1,944
Consolidated Statements of Stockholders’ Equity        
Total stockholders' equity   3,176   1,944
Net income   (2,145)    
Stock options exercised and restricted stock awards granted   0    
Share-based compensation   3,377    
Stock repurchased and retired   0    
Operating Activities        
Net income   (2,145)    
Adjustments to reconcile net income to net cash provided by operating activities:        
Depreciation and amortization   0    
Provision for losses on accounts receivable, net of adjustments   0    
Provision for excess and obsolete inventories   0    
Share-based compensation   3,377    
Loss (gain) on disposition of assets   0    
Foreign currency transaction (gain) loss   0    
Interest income on note receivable   0    
Deferred income taxes   (978)    
Changes in assets and liabilities:        
Accounts receivable   0    
Income taxes   (84)    
Inventories   0    
Prepaid expenses and other   0    
Accounts payable   0    
Deferred revenue   0    
Accrued liabilities and donations   (338)    
Net cash provided by operating activities   0    
Investing Activities        
Capital expenditures   0    
Proceeds from sale of property, plant and equipment   0    
Principal payments from note receivable   0    
Net cash used in investing activities   0    
Financing Activities        
Stock options exercised   0    
Repurchase of stock   0    
Employee taxes paid by withholding shares   0    
Net cash used in financing activities   0    
Net increase in cash, cash equivalents and restricted cash   0    
Cash, cash equivalents and restricted cash, beginning of period   0    
Cash, cash equivalents and restricted cash, end of period   0    
Corrections | Common Stock        
Balance Sheet Data (at end of period):        
Total stockholders' equity   $ 0   $ 0
Consolidated Statements of Stockholders’ Equity        
Shares, Outstanding   0   0
Total stockholders' equity   $ 0   $ 0
Stock options exercised and restricted stock awards granted (in shares)   0    
Stock options exercised and restricted stock awards granted   $ 0    
Stock repurchased and retired (in shares)   0    
Stock repurchased and retired   $ 0    
Corrections | Paid-in Capital        
Balance Sheet Data (at end of period):        
Total stockholders' equity   3,377   0
Consolidated Statements of Stockholders’ Equity        
Total stockholders' equity   3,377   0
Stock options exercised and restricted stock awards granted   0    
Share-based compensation   3,377    
Stock repurchased and retired   0    
Corrections | Retained Earnings        
Consolidated Statements of Income        
Net income   (2,145)    
Balance Sheet Data (at end of period):        
Total stockholders' equity   (201)   1,944
Consolidated Statements of Stockholders’ Equity        
Total stockholders' equity   (201)   $ 1,944
Net income   (2,145)    
Stock repurchased and retired   0    
Operating Activities        
Net income   (2,145)    
Corrections | Cost of Sales        
Balance Sheet Data (at end of period):        
Share-based compensation   400    
Corrections | Selling, General and Administrative Expenses        
Balance Sheet Data (at end of period):        
Share-based compensation   3,000    
Profit sharing bonus plan expense   $ 400